Mirati Therapeutics, Inc.

WELLS FARGO & COMPANY/MN

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/9/2024

Shares

9,665

Value ($000)

568

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/9/2024	568	0.0%	9,665	12/31/2023
2023 Q3	11/13/2023	6,466	0.0%	148,447	9/30/2023
2023 Q2	8/15/2023	3,926	0.0%	108,673	6/30/2023
2023 Q1	5/12/2023	3,791	0.0%	101,966	3/31/2023
2022 Q4	2/13/2023	3,337	0.0%	73,642	12/31/2022
2022 Q3	11/14/2022	4,586	0.0%	65,676	9/30/2022
2022 Q2	8/12/2022	4,720	0.0%	70,318	6/30/2022
2022 Q1	5/16/2022	7,521	0.0%	91,464	3/31/2022
2021 Q4	2/14/2022	9,230	0.0%	62,917	12/31/2021
2021 Q3	11/15/2021	50,592	0.0%	285,982	9/30/2021
2021 Q2	8/16/2021	52,629	0.0%	325,812	6/30/2021
2021 Q1	5/13/2021	55,473	0.0%	323,835	3/31/2021
2020 Q4	2/9/2021	65,950	0.0%	300,266	12/31/2020
2020 Q3	11/5/2020	34,951	0.0%	210,479	9/30/2020
2020 Q2	8/13/2020	6,702	0.0%	58,699	6/30/2020
2020 Q1	5/14/2020	3,485	0.0%	45,334	3/31/2020
2019 Q4	2/14/2020	5,188	0.0%	40,261	12/31/2019
2014 Q1	5/15/2014	68	0.0%	3,559	3/31/2014
2013 Q4	2/6/2014	11	0.0%	677	12/31/2013